No Data
Arcutis Biotherapeutics(ARQT.US) Officer Sells US$68,581.99 in Common Stock
$Arcutis Biotherapeutics(ARQT.US)$ Officer Edwards Larry Todd sold 7,640 shares of common stock on May 17, 2024 at an average price of $8.9767 for a total value of $68,581.99.Source: Announcement What
Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's Is How to Trade
Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating
Arcutis Biotherapeutics (ARQT) has an average outperform rating and a price target range of $12 to $26, according to analysts polled by Capital IQ. Price: 9.57, Change: +1.44, Percent Change: +17.65
Arcutis Biotherapeutics Is Maintained at Buy by Needham
Arcutis Biotherapeutics Is Maintained at Buy by Needham
NEXTracker Posts Upbeat Earnings, Joins Monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones gaining around 150 points on Wednesday.Shares of Nextracker Inc. (NASDAQ:NXT) rose sharply during Wednesday's session after the company reported better-than
OPEN, BCRX and AWIN Among Pre-market Gainers